• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Risperidone versus placebo for schizophrenia

RD Rattehalli, MB Jayaram, M Smith

Schizophrenia Bulletin | OXFORD UNIV PRESS | Published : 2010

DOI: 10.1093/schbul/sbq030

University of Melbourne Researchers

Mahesh Jayaram's Profile Picture
Mahesh Jayaram Author

Grants

Funding Acknowledgements

We wish to thank Clive Adams, Beth York and Sam Roberts from the Cochrane Schizophrenia Group for their help and support with this review.r Internal sourcesr Leeds Partnerships NHS Foundation Trust, UKr External sourcesr University of Nottingham, UK.

Citation metrics

5Scopus
3Web of Science
16Web of Science
5Dimensions
21Dimensions

Keywords

Randomized Clinical Trials
Life Sciences & Biomedicine
5202 Biological Psychology
Science & Technology
Randomized Controlled-Trials
Medicine, General & Internal
Systematic Review
Clinical Research
Severe Tardive-Dyskinesia
Double-Blind
Mental Health
3214 Pharmacology and Pharmaceutical Sciences
Vitamin-E Treatment
Conventional Antipsychotic-Drugs
6.1 Pharmaceuticals
Psychiatry
Donepezil Adjunctive Treatment
Negative Symptoms
Cognitive Impairment
3202 Clinical Sciences
32 Biomedical and Clinical Sciences
Term Treatment
Long-Acting Risperidone
Serious Mental Illness
Brain Disorders
Mental Illness
Meta-Analysis
General & Internal Medicine
Clinical Trials and Supportive Activities
52 Psychology

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224